What are the follow-up reactions caused by "Bengbu style" drug purchase?

Source: pharmaceutical economic news 2015-05-05 with the official response of Bengbu, Anhui Province, to a series of questions about "purchasing with volume", the focus of the industry gradually shifted to a series of follow-up reactions that may be brought about by the event It can be seen that Bengbu's "volume procurement" revealed some new ideas at the government level in the implementation, which may be fatal for pharmaceutical companies On the one hand, "purchasing with quantity" Classified procurement is carried out according to different products and attributes, while grouping and price reduction are based on the analysis and evaluation of the expert team under the official support, and the classified procurement ideas are implemented in detail at the local level; on the other hand, the hospital really participates in the procurement, so that the academic ability of experts has a valuable role in drug procurement, that is, exclusive ingredients or composed exclusive products, does not mean With the irreplaceable in clinical application, the real scarcity of products may be the decisive factor in the future bidding procurement, otherwise the competitive pressure may increase greatly Anhui or the whole country? Looking back on the purchasing process of Bengbu, we can find that the leading purchasing party is well prepared, from the issuance of inquiry notice to the completion of purchasing According to the official results, the procurement was completed in just one day Among them, more than 20 kinds of drugs have won the bid for single type and volume inquiry procurement, with a 25% drop in drug price; 5 out of the city and 5 in the city and 10 distribution enterprises have been determined as bid winning suppliers through package competitive negotiation procurement The centralized purchase of drugs involves more than 2600 kinds of drugs The concentration of bid winning enterprises has greatly increased The bid winning rate of large-scale enterprises with good quality control has significantly increased, and the bid winning price of drugs has also significantly decreased Compared with the current market average price, the packaged "volume purchase" of the same drugs has decreased by 17.24%, with a maximum decrease of 22.5%, and the profit amount has exceeded 80 million yuan According to the previous requirements of Bengbu, there are 30 varieties listed in the list of single varieties If the enterprise does not reach 25% of the profit margin, it will not be able to enter 94 public medical institutions in the city The precise data of 25% reduction of "volume purchase" in Bengbu has aroused a lot of questions in the industry, but this does not affect the official implementation of this requirement At the same time of completing the bidding results, Bengbu official announced that the price reduction of drugs listed in the "volume purchase" catalogue of a single variety is less than 25% , the notice that all its drugs shall not be sold in all public medical institutions of Bengbu City permanently, including Shandong Danhong Pharmaceutical Co., Ltd., Beijing Sihuan Pharmaceutical Co., Ltd., Harbin Songhe Pharmaceutical Co., Ltd., Jiangsu aosaikang Pharmaceutical Co., Ltd., Dali Pharmaceutical Co., Ltd., HongRi Pharmaceutical Co., Ltd., GSK, etc., all of which are well-known brand manufacturers Therefore, the attention of "purchasing with quantity" in Bengbu is pushed to a high point There are two reasons why Bengbu has become the focus of the industry: first, the government clearly defines the price reduction range in the "volume procurement" with a strong attitude and accurate reduction; second, does the tough of Bengbu only represent Bengbu or Anhui? In fact, no matter how much the price of Bengbu is reduced, it is only a prefecture level city after all But is it Anhui province that is making some explorations behind the "volume purchase" link of Bengbu? Anhui Province is one of the most important trials in the reform of drug bidding This is the key to the national attention of this incident "Previously, the State Council level documents have made it clear that they support the establishment of joint procurement bodies at Prefecture and municipal levels, which means that political risks need not be considered at the local level." Vice president of sales of a state-owned enterprise in Sichuan told reporters However, the state has no clear requirements on the specific implementation mode and content of the procurement body Since the issuance of the document, Anhui, Zhejiang, Sichuan, Chongqing and other places have tried out a variety of consortiums and "volume procurement" models, and "secondary price reduction" has been basically used at the same time "At present, the situation of national drug procurement has put a great pressure on drug manufacturers In the past, it may be more in the field of basic drugs, but in the future, it will be more in the field of medical insurance products, whether it is bidding or" purchasing with volume " We hope to have a precise market strategy and expand the market share as much as possible under the inevitable situation of making profits " Hebei a pharmaceutical factory sales director said In fact, from a series of games between Bengbu bidding enterprises and the government, we can see that the leading Party's thinking on drug procurement has entered a new stage From the national level, the idea of classified bidding has been very clear, while Bengbu's bidding procurement emphasizes the special treatment of special varieties, which can even be considered as the refinement of classified procurement ideas First of all, in response to the reasons for the 25% price reduction that the industry loudly questioned, the person in charge of the medical and Political Department of Bengbu health and Family Planning Commission said that the price reduction of 30 drugs included in the list of single products was 25% through the collective demonstration of experts, which was considered by the government to be completely within the range of enterprises Therefore, Bengbu requires enterprises to achieve this reduction According to the reporter, Bengbu has negotiated with relevant enterprises during the inquiry process with pharmaceutical enterprises And the rest of the products, although also a substantial price reduction, are still not comparable to the products in the single product catalog, and there is no requirement for a unified price reduction In addition, the enterprise needs to pay special attention to the fact that the head of the medical administration department of the health and Family Planning Commission of Bengbu City mentioned that the individual products of the banned pharmaceutical enterprises are exclusive products, and Bengbu will actively seek alternative products Does this send a signal that officials are aware that there are alternatives in clinical applications, even for exclusive varieties This may be the biggest difference from the common name as the standard in the past bidding How much market competition pressure will be increased for the exclusive or similar exclusive products, or even the products with few original approvals, if the procurement method of disease treatment or department application is implemented? Facing the change of Bengbu drug purchase mode, how should enterprises choose? According to relevant information, Bengbu officials had previously communicated with the banned pharmaceutical companies, but they did not reach a consensus to reduce the price by 25% The head of government affairs of a foreign-funded enterprise told reporters that all the products banned were the products of large manufacturers Manufacturers do not want to see Bengbu as a prefecture level market, which destroys the hard-working price maintenance system, so as not to damage the national market due to the linkage of bidding prices On the other hand, in addition to the manufacturers who agreed to reduce the price at the beginning, according to the official website of Bengbu, after the announcement of the bidding results, some single variety manufacturers contacted Bengbu's official website and applied to be included in the transaction directory according to the inquiry requirements, including olactam injection solution, pantoprazole sodium injection, calf blood protein free extract injection, ceftazidime for injection Ting Na injection, Xueshuantong for injection (freeze dry) and other products The reason why these products are finally "soft" is probably closely related to their scarcity and irreplaceable And the firm attitude of the blocked enterprises is to have enough confidence in the scarcity of the product market, or to seek the second market wait-and-see? can make nothing of it.